Compare iShares MSCI Singapore ETF (EWS) vs Edgewise Therapeutics Inc. Common Stock (EWTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Singapore ETF vs Edgewise Therapeutics Inc. Common Stock — how do they compare? iShares MSCI Singapore ETF trades at $31.02 (market cap $1.23B), while Edgewise Therapeutics Inc. Common Stock trades at $37.3 (market cap $4.02B). The key difference: Edgewise Therapeutics Inc. Common Stock is far larger — about 3.3× iShares MSCI Singapore ETF's market cap, and Edgewise Therapeutics Inc. Common Stock is trading nearer its 52-week high, iShares MSCI Singapore ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Singapore ETF for 47 Days and Edgewise Therapeutics Inc. Common Stock for 0 Days on average.
| EWS | EWTX | |
|---|---|---|
Market Cap | $1.23B | $4.02B |
Volume | 1,492,494 | 1,446,128 |
Sector | Broad Market / Factor | Health |
52-Week High | $34.57 | $48.35 |
52-Week Low | $26.71 | $14.89 |
Typical Hold Time | 47 Days | 0 Days |
Enterprise Value | — | $3.56B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares MSCI Singapore ETF
EWS tracks the MSCI Singapore 25/50 Index, providing targeted exposure to large and mid-cap companies in Singapore. It is heavily weighted toward the financial, industrial, and real estate sectors, serving as a liquid tool for accessing Singapore's stable, dividend-oriented developed economy.
Read more on EWS →About Edgewise Therapeutics Inc. Common Stock
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →
